Controlled release of theophylline through semi-interpenetrating network microspheres of chitosan-(dextran-g-acrylamide)

被引:18
作者
Al-Kahtani, Ahmed A. [1 ]
Sherigara, B. S. [1 ]
机构
[1] Kuvempu Univ, Dept Ind Chem, Sch Chem Sci, Shankaraghatta 577451, Karnataka, India
关键词
DEGRADABLE DEXTRAN HYDROGELS; CONTROLLED DRUG-DELIVERY; CHITOSAN MICROSPHERES; IN-VITRO; MICROCAPSULES; COPOLYMER; MATRIX; BIOMATERIAL; SYSTEMS; BLOOD;
D O I
10.1007/s10856-009-3704-6
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
Semi-interpenetrating network microspheres of chitosan-(dextran-g-acrylamide) were prepared by emulsion-crosslinking method using glutaraldehyde (GA) as a crosslinking agent. Graft copolymerization of dextran with acrylamide (Dx-g-AAm) was carried out by aqueous free-radical polymerization using ceric ammonium nitrate (CAN) as initiator. The grafting efficiency was found to be 92%. Theophylline (TH), antiasthmatic drug, was successfully encapsulated into semi-INP microspheres by varying the ratio of Dx-g-AAm and amount of GA. The laser light scattering technique shows that the particles size increased with increasing amount of graft copolymer and decrease with increasing amount of GA. The % encapsulation efficiency was found to vary between 50 and 78. MPs were characterized by FTIR spectroscopy and differential scanning calorimetry (DSC) techniques to confirm the graft copolymer, formation of semi-IPN structure of MPs and molecular distribution of the drug molecules in the polymer matrix. In vitro release studies of TH from these matrices have been investigated at Ph 1.2 and 7.4 media and the slow release were extended up to 18 h at 37 degrees C. The release rates were fitted to an empirical equation to estimate the diffusion exponent n, which indicated that the release from the MPs follows non-Fickian type.
引用
收藏
页码:1437 / 1445
页数:9
相关论文
共 45 条
[1]
Synthesis of iron-crosslinked chitosan succinate and iron-crosslinked hydroxamated chitosan succinate and their in vitro evaluation as potential matrix materials for oral theophylline sustained-release beads [J].
Aiedeh, K ;
Taha, MO .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :159-168
[2]
ARTURSSON P, 1984, J PHARM SCI-US, V73, P1507, DOI 10.1002/jps.2600731103
[3]
Baker R.W., 1974, Controlled Release of Biologically active Agents, P15, DOI 10.1007/978-1-4684-7239-4_2
[4]
EFFECT OF POLYISOBUTYLENE ON ETHYLCELLULOSE-WALLED MICROCAPSULES - WALL STRUCTURE AND THICKNESS OF SALICYLAMIDE AND THEOPHYLLINE MICROCAPSULES [J].
BENITA, S ;
DONBROW, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (02) :205-210
[5]
CASU B, 1990, MACROMOLECOLE SCI TE, P5
[6]
CHITOSAN - AS A BIOMATERIAL [J].
CHANDY, T ;
SHARMA, CP .
BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1990, 18 (01) :1-24
[7]
EDMAN P, 1980, J PHARM SCI-US, V69, P838, DOI 10.1002/jps.2600690725
[8]
EFFECTS OF A POSITIVELY CHARGED BIOMATERIAL FOR DERMAL AND SUBCUTANEOUS AUGMENTATION [J].
EPPLEY, BL ;
SUMMERLIN, DJ ;
PREVEL, CD ;
SADOVE, AM .
AESTHETIC PLASTIC SURGERY, 1994, 18 (04) :413-416
[9]
Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: A placebo-controlled parallel group study [J].
Finnerty, JP ;
Lee, C ;
Wilson, S ;
Madden, J ;
Djukanovic, R ;
Holgate, ST .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (08) :1672-1677
[10]
Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres [J].
Franssen, O ;
Vandervennet, L ;
Roders, P ;
Hennink, WE .
JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) :211-221